Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Clonal Evolution In Patients With Previously Untreated Chronic Lymphocytic Leukemia

Sameer A. Parikh, MD, Kari G. Rabe, MS, Stephanie A. Smoley, Anne E. Wiktor, Curtis A. Hanson, MD, Tait D. Shanafelt, MD, Daniel L. Van Dyke, Ph.D.

Blood (2013) 122 (21): 1643.

https://doi.org/10.1182/blood.V122.21.1643.1643

Published: 2013

Journal Articles

Diagnostic and Prognostic Significance Of Isolated Trisomy 2 In Hematopoietic Malignancies

Umut Aypar, PhD, Lindsey Waltman, MS, Kaaren Reichard, MD, Daniel L. Van Dyke, Ph.D.

Blood (2013) 122 (21): 4970.

https://doi.org/10.1182/blood.V122.21.4970.4970

Published: 2013

Journal Articles

Loss of the Y Chromosome Predicts Lower Complete Cytogenetic Remission Rate in Patients (pts) with Chronic Myeloid Leukemia (CML)

Mohamed Abdelfatah, Adel Al-Alwan, Zeyad Kanaan, Mark R Litzow, MD, Alexandra Wolanskyj, Kebede Begna, William Hogan, MD, Daniel L. Van Dyke, Ph.D., Aref Al-Kali, MD

Blood (2012) 120 (21): 4804.

https://doi.org/10.1182/blood.V120.21.4804.4804

Published: 2012

Journal Articles

Very High Risk CLL Characterized by a “Double Hit” Clone with Both 11q22 and 17p13 Deletion.

Patricia T. Greipp, D.O., Stephanie A. Smoley, David S. Viswanatha, MD, Lori S. Frederick, BS, Ruchi G. Sharma, Kari G. Rabe, MS, Susan L Slager, PhD, Daniel L. Van Dyke, Ph.D., Neil E. Kay, MD, Tait D. Shanafelt, MD, Clive S. Zent, MD

Blood (2012) 120 (21): 2486.

https://doi.org/10.1182/blood.V120.21.2486.2486

Published: 2012

Journal Articles

FISH Scoring for CLL: Comparison of Methods That Assess Round Versus Non-Round Nuclei,

Patricia T. Greipp, D.O., Stephanie A. Smoley, Neil Kay, MD, Clive S. Zent, MD, Jeannette E. Eckel-Passow, Ph.D., Ruchi G. Sharma, Daniel L. Van Dyke, Ph.D.

Blood (2011) 118 (21): 3538.

https://doi.org/10.1182/blood.V118.21.3538.3538

Published: 2011

Journal Articles

Leukemia Risk Models in Primary Myelofibrosis: An International Working Group Study,

Ayalew Tefferi, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MD, Kebede Begna, MD, Curtis A. Hanson, MD, Daniel L. Van Dyke, Ph.D., Domenica Caramazza, Alessandro M. Vannucchi, MD, Enrica Morra, Mario Cazzola, Arturo Pereira, MD. PhD, Francisco Cervantes, MD, Francesco Passamonti, MD

Blood (2011) 118 (21): 3833.

https://doi.org/10.1182/blood.V118.21.3833.3833

Published: 2011

Journal Articles

Predictors of Greater Than 80% Two-Year Mortality in Primary Myelofibrosis: A Mayo Clinic Study of 884 Karyotypically-Annotated Cases

Ayalew Tefferi, MD, Naseema Gangat, MD, Rakhee Vaidya, MD, Kebede Begna, MD, Curtis A. Hanson, MD, Daniel L. Van Dyke, Ph.D., Domenica Caramazza, Animesh Pardanani, MBBS, PhD

Blood (2011) 118 (21): 2806.

https://doi.org/10.1182/blood.V118.21.2806.2806

Published: 2011

Journal Articles

Longitudinal Genome Wide Analysis of Patients with Chronic Lymphocytic Leukemia Reveals Complex Evolution of Clonal Architecture At Disease Progression and At the Time of Relapse

Esteban Braggio, PhD, Neil Kay, MD, Scott Van Wier, Renee C. Tschumper, Stephanie A. Smoley, Jeanette E. Eckel-Passow, Ph.D., Traci Sassoon, Daniel L. Van Dyke, Ph.D., John C. Byrd, MD, Diane F. Jelinek, Ph.D., Tait D. Shanafelt, MD, Rafael Fonseca, MD

Blood (2011) 118 (21): 2838.

https://doi.org/10.1182/blood.V118.21.2838.2838

Published: 2011

Journal Articles

Global Genomic Status At Diagnosis Informs Clinical Outcome in B-Chronic Lymphocytic Leukemia: Stable Versus Progressive Disease

Daniel L. Van Dyke, Ph.D., Jeannette G Rustin, Stephanie A. Smoley, Jeanette Eckel Passow, Ph.D., Ruchi G. Sharma, Esteban Braggio, PhD, Tait D. Shanafelt, MD, Neil Kay, MD

Blood (2011) 118 (21): 1772.

https://doi.org/10.1182/blood.V118.21.1772.1772

Published: 2011

Journal Articles

FISH Redoux — A Novel Way to Emulate CLL Leukemic Cells From Buffy Coat Samples

Stephanie A. Smoley, Patricia T. Greipp, D.O., Neil E. Kay, M.D., Tait D. Shanafelt, MD, Jeanette E. Eckel-Passow, Ph.D., Ruchi G. Sharma, Daniel L. Van Dyke, Ph.D.

Blood (2010) 116 (21): 3606.

https://doi.org/10.1182/blood.V116.21.3606.3606

Published: 2010

NARROW

Clonal Evolution In Patients With Previously Untreated Chronic Lymphocytic Leukemia

Diagnostic and Prognostic Significance Of Isolated Trisomy 2 In Hematopoietic Malignancies

Loss of the Y Chromosome Predicts Lower Complete Cytogenetic Remission Rate in Patients (pts) with Chronic Myeloid Leukemia (CML)

Very High Risk CLL Characterized by a “Double Hit” Clone with Both 11q22 and 17p13 Deletion.

FISH Scoring for CLL: Comparison of Methods That Assess Round Versus Non-Round Nuclei,

Leukemia Risk Models in Primary Myelofibrosis: An International Working Group Study,

Predictors of Greater Than 80% Two-Year Mortality in Primary Myelofibrosis: A Mayo Clinic Study of 884 Karyotypically-Annotated Cases

Longitudinal Genome Wide Analysis of Patients with Chronic Lymphocytic Leukemia Reveals Complex Evolution of Clonal Architecture At Disease Progression and At the Time of Relapse

Global Genomic Status At Diagnosis Informs Clinical Outcome in B-Chronic Lymphocytic Leukemia: Stable Versus Progressive Disease

FISH Redoux — A Novel Way to Emulate CLL Leukemic Cells From Buffy Coat Samples

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only